Reports indicate increasing incidence of Type I allergic reactions to
latex allergens. The proteins that act as allergens and produce such a
llergic reactions are found in the natural latex sap of Hevea brasilie
nsis. All those who are exposed to latex products, particularly health
care workers, are potentially at risk. The lack of qualified allergen
extracts makes it difficult to perform skin testing on individuals who
are at high risk. Therefore, a reliable in vitro test system for the
detection of IgE antibodies to latex would be of considerable utility.
We have developed a serological test for the qualitative determinatio
n of specific IgE antibodies to latex. In our study, 75 sera from indi
viduals with a history of latex allergy and 29 serum samples from heal
thcare workers were tested by both radioimmunoassay (RIA) and enzyme i
mmunoassay (EIA). The allergen bound to paper discs was the same solid
phase for the RIA and EIA assays. The allergen preparation used for c
oating the paper discs was a mixture of proteins obtained from raw lat
ex. The data show a good correlation between the results of RIA and EI
A methods with data obtained using an RIA assay at an independent labo
ratory and by skin prick testing. Comparing the performance of our tes
t using our latex material with that of the latex material obtained fr
om the Food and Drug Administration (FDA), along with results of other
tests including skin tests, we found that the specificity and sensiti
vity of our assay method approaches 100%. The data show no significant
cross-reactivity between latex and banana. A low Level of cross-react
ivity between latex and avocado was observed. We conclude that, by usi
ng correct selection of proteins, the detection of specific IgE to lat
ex may be a valuable assay method for screening individuals and for th
e diagnosis of allergy to latex.